Pharmaceuticals: Watch For Tighter Medicaid Rebate Enforcement
AWP could shrink to AMOP after government pricing investigation.Drugmakers, you saw this one coming. Medicaid drug pricing is taking a seat at the top of the congressional "to-do" list.The Committee on Energy and Commerce is launching an "extensive investigation" into pharmaceutical reimbursement under Medicaid, and that means drug companies can expect to see states become more aggressive about collecting Medicaid rebates.In a letter to the General Accounting Office Feb. 4, Subcommittee on Oversight & Investigations Chairman James Greenwood (R-PA) says he wants the watchdog agency to set its sights on controlling Medicaid drug costs which have...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: